Cabio Biotech (China) Alpha and Beta Analysis

688089 Stock   24.48  0.99  3.89%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cabio Biotech Wuhan. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cabio Biotech over a specified time horizon. Remember, high Cabio Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cabio Biotech's market risk premium analysis include:
Beta
0.17
Alpha
0.19
Risk
3.29
Sharpe Ratio
0.0607
Expected Return
0.2
Please note that although Cabio Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Cabio Biotech did 0.19  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Cabio Biotech Wuhan stock's relative risk over its benchmark. Cabio Biotech Wuhan has a beta of 0.17  . As returns on the market increase, Cabio Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cabio Biotech is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Cabio Biotech Backtesting, Cabio Biotech Valuation, Cabio Biotech Correlation, Cabio Biotech Hype Analysis, Cabio Biotech Volatility, Cabio Biotech History and analyze Cabio Biotech Performance.

Cabio Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cabio Biotech market risk premium is the additional return an investor will receive from holding Cabio Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cabio Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cabio Biotech's performance over market.
α0.19   β0.17

Cabio Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cabio Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Cabio Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Cabio Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how Cabio Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cabio Biotech shares will generate the highest return on investment. By understating and applying Cabio Biotech stock market price indicators, traders can identify Cabio Biotech position entry and exit signals to maximize returns.

Cabio Biotech Return and Market Media

The median price of Cabio Biotech for the period between Fri, Dec 13, 2024 and Thu, Mar 13, 2025 is 21.16 with a coefficient of variation of 10.23. The daily time series for the period is distributed with a sample standard deviation of 2.15, arithmetic mean of 21.06, and mean deviation of 1.85. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Cabio Biotech Co., Ltd. Surges 26 percent Yet Its Low PE Is No Reason For Excitement - Simply Wall St
03/07/2025

About Cabio Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cabio or other stocks. Alpha measures the amount that position in Cabio Biotech Wuhan has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cabio Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cabio Biotech's short interest history, or implied volatility extrapolated from Cabio Biotech options trading.

Build Portfolio with Cabio Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in Cabio Stock

Cabio Biotech financial ratios help investors to determine whether Cabio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cabio with respect to the benefits of owning Cabio Biotech security.